At a glance
- Originator Teikoku Hormone
- Mechanism of Action Endothelin A receptor antagonists; Endothelin B receptor antagonists; Type 3 cyclic nucleotide phosphodiesterase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Reperfusion injury